Peer Review reports
From: Tumorigenic role of Pak4 in ovarian cancer and its correlation with immune infiltration
| Original Submission | ||
|---|---|---|
| 4 Feb 2024 | Submitted | Original manuscript |
| 1 Mar 2024 | Reviewed | Reviewer Report |
| 16 Mar 2024 | Reviewed | Reviewer Report |
| 4 Apr 2024 | Author responded | Author comments - Lan Yu |
| Resubmission - Version 2 | ||
| 4 Apr 2024 | Submitted | Manuscript version 2 |
| 5 Apr 2024 | Author responded | Author comments - Lan Yu |
| Resubmission - Version 3 | ||
| 5 Apr 2024 | Submitted | Manuscript version 3 |
| 15 Apr 2024 | Author responded | Author comments - Lan Yu |
| Resubmission - Version 4 | ||
| 15 Apr 2024 | Submitted | Manuscript version 4 |
| 18 Apr 2024 | Author responded | Author comments - Lan Yu |
| Resubmission - Version 5 | ||
| 18 Apr 2024 | Submitted | Manuscript version 5 |
| 7 May 2024 | Author responded | Author comments - Lan Yu |
| Resubmission - Version 6 | ||
| 7 May 2024 | Submitted | Manuscript version 6 |
| Publishing | ||
| 17 May 2024 | Editorially accepted | |
| 28 May 2024 | Article published | 10.1186/s12920-024-01917-4 |
You can find further information about peer review here.